NYSE American - Nasdaq Real Time Price USD

InfuSystem Holdings, Inc. (INFU)

8.01 +0.27 (+3.51%)
As of 3:36 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
125,785.00
125,785.00
109,914.00
102,382.00
97,388.00
Cost of Revenue
62,676.00
62,676.00
49,354.00
43,846.00
38,629.00
Gross Profit
63,109.00
63,109.00
60,560.00
58,536.00
58,759.00
Operating Expense
59,021.00
59,021.00
58,906.00
55,716.00
49,932.00
Operating Income
4,088.00
4,088.00
1,654.00
2,820.00
8,827.00
Net Non Operating Interest Income Expense
-2,170.00
-2,170.00
-1,402.00
-1,377.00
-1,255.00
Other Income Expense
-67.00
-67.00
-122.00
-186.00
-29.00
Pretax Income
1,851.00
1,851.00
130.00
1,257.00
7,543.00
Tax Provision
979.00
979.00
112.00
-163.00
-9,789.00
Net Income Common Stockholders
872.00
872.00
18.00
1,420.00
17,332.00
Diluted NI Available to Com Stockholders
872.00
872.00
18.00
1,420.00
17,332.00
Basic EPS
0.04
0.04
0.00
0.07
0.86
Diluted EPS
0.04
0.04
0.00
0.06
0.80
Basic Average Shares
21,024.38
21,024.38
20,648.82
20,519.96
20,106.94
Diluted Average Shares
21,646.08
21,646.08
21,547.31
22,049.66
21,717.22
Total Operating Income as Reported
4,088.00
4,088.00
1,654.00
2,820.00
8,827.00
Total Expenses
121,697.00
121,697.00
108,260.00
99,562.00
88,561.00
Net Income from Continuing & Discontinued Operation
872.00
872.00
18.00
1,420.00
17,332.00
Normalized Income
872.00
872.00
18.00
1,420.00
17,332.00
Interest Expense
2,170.00
2,170.00
1,402.00
1,377.00
1,255.00
Net Interest Income
-2,170.00
-2,170.00
-1,402.00
-1,377.00
-1,255.00
EBIT
4,021.00
4,021.00
1,532.00
2,634.00
8,798.00
EBITDA
16,529.00
16,529.00
14,892.00
17,259.00
22,823.00
Reconciled Cost of Revenue
51,158.00
51,158.00
38,488.00
33,483.00
28,889.00
Reconciled Depreciation
12,508.00
12,508.00
13,360.00
14,625.00
14,025.00
Net Income from Continuing Operation Net Minority Interest
872.00
872.00
18.00
1,420.00
17,332.00
Normalized EBITDA
16,529.00
16,529.00
14,892.00
17,259.00
22,823.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
12/31/2020 - 12/27/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CLPBF Coloplast A/S
124.23
0.00%
 
TRUMF Terumo Corporation
16.61
+0.73%
 
NEPH Nephros, Inc.
2.1100
+2.43%
 
ATRI Atrion Corporation
413.68
+3.46%
 
MLSS Milestone Scientific Inc.
0.5500
+1.85%
 
UTMD Utah Medical Products, Inc.
67.87
-0.39%
 
ANIK Anika Therapeutics, Inc.
25.85
-0.39%
 
MMSI Merit Medical Systems, Inc.
74.29
+1.41%
 
HBIO Harvard Bioscience, Inc.
3.7000
0.00%
 
ICUI ICU Medical, Inc.
97.85
+1.53%